S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Revenue Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Revenue
kr838.2m
CAGR 3-Years
82%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Revenue
kr18.1B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Revenue
kr726.4m
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
13%
Getinge AB
STO:GETI B
Revenue
kr31.8B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Revenue
kr11B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Revenue
kr429.7m
CAGR 3-Years
41%
CAGR 5-Years
24%
CAGR 10-Years
18%

See Also

What is Surgical Science Sweden AB's Revenue?
Revenue
838.2m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Revenue amounts to 838.2m SEK.

What is Surgical Science Sweden AB's Revenue growth rate?
Revenue CAGR 5Y
65%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Surgical Science Sweden AB have been 82% over the past three years , 65% over the past five years .

Back to Top